ENDRA Life Sciences (NDRA) Inventory Average (2017 - 2024)

ENDRA Life Sciences (NDRA) has reported Inventory Average for 8 consecutive years, with $2.7 million the latest figure, recorded in Q3 2024.

• In Q3 2024, Inventory Average fell 1.66% year-over-year to $2.7 million; the TTM figure through Sep 2024 stood at $2.7 million (down 1.66% YoY), while the FY2023 annual figure was $2.6 million, up 34.06% from the prior year.
• Inventory Average steadied at $2.7 million in Q3 2024 per NDRA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Inventory Average topped out at $2.8 million in Q3 2023 and bottomed at $144188.5 in Q1 2020.
• Historically, Inventory Average has averaged $1.8 million across 5 years, with a median of $2.2 million in 2022.
• Annual changes were most pronounced in 2021 — Inventory Average surged 356.43% — and 2024, when it dropped 1.66%.
• ENDRA Life Sciences' Inventory Average stood at $456414.0 in 2020, then jumped by 205.02% to $1.4 million in 2021, then surged by 89.59% to $2.6 million in 2022, then increased by 1.93% to $2.7 million in 2023, then gained by 0.81% to $2.7 million in 2024.
• Business Quant data shows NDRA's Inventory Average at $2.7 million in Q3 2024, $2.7 million in Q2 2024, and $2.7 million in Q1 2024.